Lucentis beats lasers in treating diabetic retinopathy

A study funded by the National Eye Institute determined that Lucentis injections trumped laser therapy in treating proliferative diabetic retinopathy. The study results were published in the Journal of the American Medical Association online. 305 patients were included in the study with half of them receiving monthly Lucentis injections for three months and then only […]

Annual dilated eye exams crucial for diabetic patients

Diabetic patients are encouraged to get an annual dilated eye exam and with November being Diabetic Eye Disease Awareness Month, prevention strategies are being stressed. Diabetes is the leading cause of new cases of blindness in adults. Close monitoring by an eye care professional can help lessen diabetes’ impact on vision and with diabetics being […]

New imaging device will help diagnose eye diseases at earlier stages

A new eye imaging device developed by OcuSciences determines eye health by measuring patterns and tissues in the eye. The results of these measurements and patterns can help eye care professionals detect eye diseases such as diabetes at an earlier stage. This new device, the OcuMet Beacon, has been in development since 2008. The device […]

Eylea on fast track for diabetic retinopathy treatment

Regeneron Pharmaceuticals announced that the FDA has classified Eylea as a breakthrough therapy to treat diabetic retinopathy in patients who already have diabetic macular edema.This classification expedites the process for Eylea to be FDA approved. Currently, Eylea has FDA approval for treatment of wet age-related macular degeneration, macular edema associated with central retinal vein occlusion […]

Google’s smart lens technology pairs with Alcon

Google has licensed its “smart lens” technology to Alcon for all ocular medical uses. The collaboration between the technology giant and the eye care giant will include developing a “smart lens” to address ocular conditions. The advances that Google has made in miniaturization of electronics will help Alcon in its endeavors to improve the ways […]

VisiVite® Eye Formulas for Diabetic Retinopathy

Diabetics with retinopathy or those who want to avoid retinopathy, would benefit from two VisiVite formulas, a study shows. The study, published in the International Journal of Ophthalmology,  showed that diabetics with retinopathy had lower lutein and zeaxanthin blood levels than those without diabetes. The authors hypothesize that this may be due to poor diet, poor absorption in the face […]

‘Sticky-trap’ therapy helps treat diabetic retinopathy

Researchers at the University of Toronto in Canada have developed a new therapy called ‘sticky-trap’ to treat diabetic retinopathy. ‘Sticky-trap’ is injected into the eye and the binding component within it attaches to the surface of cells and shuts down the abnormal blood vessels within the eye. Diabetic retinopathy causes vision loss when the extra, […]

Inflammation receptor linked to diabetic retinopathy

Researchers are looking at the role that a receptor known as Gpr109a plays in reducing eye inflammation, which could help in treating diabetic retinopathy. Diabetic retinopathy is one of the leading causes of blindness in adults in the United States. A team of scientists discovered that removing the receptor from the retina of non-diabetic mice […]

Parkinson’s drug for treating diabetic retinopathy?

Drugs that treat Parkinson’s help to restore dopamine levels in the brain and dopamine is also known to play a part in the function of the retina. Diabetic retinopathy damages the blood vessels in the eyes and restoring the dopamine levels in diabetic patients may help improve vision. Using diabetic mice, researchers at Emory University […]

Revolutionary 3-D retinal imaging technology developed by MIT

A revolutionary hand-held scanner developed by researchers at MIT scans the entire retina in just seconds using 3-D imaging technology. The practical, hand-held scanner will enable even primary care providers to detect a number of blinding eye diseases such as macular degeneration, and glaucoma in their earliest stages. Using 3-D imaging and movement-correction, this new […]